Syncom Formul.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE312C01025
  • NSEID: SYNCOMF
  • BSEID: 524470
INR
21.96
-0.13 (-0.59%)
BSENSE

Nov 20

BSE+NSE Vol: 1.73 cr

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 831770,
    "name": "Syncom Formul.",
    "stock_name": "Syncom Formul.",
    "full_name": "Syncom Formulations (India) Ltd",
    "name_url": "stocks-analysis/syncom-formul",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "21.96",
    "chg": -0.13,
    "chgp": "-0.59%",
    "dir": -1,
    "prev_price": "22.09",
    "mcapval": "2,086.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524470,
    "symbol": "SYNCOMF",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE312C01025",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "1.73 cr",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/syncom-formul-831770-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Syncom Formulations Gains 8.18%: 3 Key Factors Driving the Move",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/syncom-formulations-gains-818-3-key-factors-driving-the-move-4270556",
        "imagepath": "",
        "date": "2026-11-21 15:03:23",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>16 Nov:</strong> Stock opens at ₹21.10, up 3.94% on strong volume</p>\n                    <p><strong>19 Nov:</strong> Mojo Grade upgraded to Buy; shares jump 5.55% to ₹22.06</p>\n                    <p><strong>20 Nov:</strong> Valuation grade shifts to very expensive amid sector dynamics</p>\n                    <p><strong>20 Nov:</strong> Week closes at ₹21.96, up 8.18% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.20.30</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs..."
      },
      {
        "title": "Syncom Formulations: Valuation Shift Signals Heightened Price Attractiveness Amidst Sector Dynamics",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/syncom-formulations-valuation-shift-signals-heightened-price-attractiveness-amidst-sector-dynamics-4268683",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/SyncomFormulati_valuationdot_4268683.png",
        "date": "2026-11-20 08:00:33",
        "description": "Syncom Formulations (India) Ltd has recently undergone a significant change in its valuation parameters, shifting from an expensive to a very expensive rating. This adjustment reflects evolving market perceptions and invites investors to reassess the stock’s price attractiveness in the context of its financial metrics, peer comparisons, and historical performance."
      },
      {
        "title": "Syncom Formulations Shares Gain Momentum as Technical Indicators Turn Bullish",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/syncom-formulations-shares-gain-momentum-as-technical-indicators-turn-bullish-4267511",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/SyncomFormulati_technicaldot_4267511.png",
        "date": "2026-11-19 08:04:07",
        "description": "Syncom Formulations (India) Ltd has demonstrated a notable shift in price momentum, moving from a mildly bullish to a bullish technical trend, supported by a confluence of positive signals across key indicators such as MACD, RSI, moving averages, and Bollinger Bands. This micro-cap pharmaceutical stock’s recent performance and technical upgrades suggest growing investor confidence amid a challenging sector backdrop."
      },
      {
        "title": "Syncom Formulations (India) Ltd is Rated Hold",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/syncom-formulations-india-ltd-is-rated-hold-4261503",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/SyncomFormulati_mojoScore_4261503.png",
        "date": "2026-11-14 10:10:04",
        "description": "Syncom Formulations (India) Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 24 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 November 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Syncom Formulations (India) Ltd Shows Bullish Momentum Amid Technical Upgrades",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/syncom-formulations-india-ltd-shows-bullish-momentum-amid-technical-upgrades-4251430",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/SyncomFormulati_technicaldot_4251430.png",
        "date": "2026-11-05 08:04:40",
        "description": "Syncom Formulations (India) Ltd has demonstrated a notable shift in price momentum, supported by a series of bullish technical indicators. The micro-cap pharmaceutical company’s recent upgrade from a Sell to a Hold rating reflects improving market sentiment and technical strength, signalling potential opportunities for investors amid a volatile sector backdrop."
      },
      {
        "title": "Syncom Formulations Falls 9.24%: 3 Key Factors Driving the Weekly Decline",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/syncom-formulations-falls-924-3-key-factors-driving-the-weekly-decline-4245877",
        "imagepath": "",
        "date": "2026-10-31 15:03:20",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Oct 26:</strong> Valuation shift signals renewed investor interest</p>\n                    <p><strong>Oct 28:</strong> Technical indicators turn bullish amid price rebound</p>\n                    <p><strong>Oct 29:</strong> Technical momentum shifts to mildly bullish with consolidation</p>\n                    <p><strong>Oct 30:</strong> Week closes lower at Rs.19.25 (-5.54% on day)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.21.21</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs..."
      },
      {
        "title": "Syncom Formulations (India) Ltd: Technical Momentum Shifts Signal Mildly Bullish Outlook",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/syncom-formulations-india-ltd-technical-momentum-shifts-signal-mildly-bullish-outlook-4242781",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/SyncomFormulati_technicaldot_4242781.png",
        "date": "2026-10-29 08:02:16",
        "description": "Syncom Formulations (India) Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a recent dip in daily price, key technical indicators such as MACD and KST maintain bullish signals on weekly and monthly charts, while moving averages and Bollinger Bands suggest cautious optimism. This nuanced technical landscape offers investors a complex picture amid broader market volatility."
      },
      {
        "title": "Syncom Formulations Shares Gain Momentum as Technical Indicators Turn Bullish",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/syncom-formulations-shares-gain-momentum-as-technical-indicators-turn-bullish-4241483",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/SyncomFormulati_technicaldot_4241483.png",
        "date": "2026-10-28 08:04:10",
        "description": "Syncom Formulations (India) Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underpinned by improvements across key technical indicators including MACD, moving averages, and Bollinger Bands, signalling renewed investor interest in this pharmaceuticals and biotechnology micro-cap stock."
      },
      {
        "title": "Syncom Formulations Valuation Shift Signals Renewed Investor Interest",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/syncom-formulations-valuation-shift-signals-renewed-investor-interest-4238214",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/SyncomFormulati_valuationdot_4238214.png",
        "date": "2026-10-26 08:01:29",
        "description": "Syncom Formulations (India) Ltd has witnessed a notable shift in its valuation parameters, moving from a very expensive to an expensive rating, reflecting a recalibration of price attractiveness amid robust financial performance and sector dynamics. This change, coupled with a recent upgrade in its Mojo Grade from Sell to Hold, underscores evolving investor sentiment in the Pharmaceuticals & Biotechnology micro-cap space."
      }
    ],
    "total": 80,
    "sid": "831770",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/syncom-formulations-india-831770"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "14-Nov-2026",
      "details": "Submission of Press Clipping regarding publication of extract of Unaudited Standalone and Consolidated Financial Results for the Quarter/Half Year ended on 30th September 2026",
      "source": "BSE"
    },
    {
      "caption": "Submission Of Standalone & Consolidated Unaudited Financial Results For The Quarter And Half Year Ended On 30Th September 2026 Pursuant To Regulation 33(3) Of The SEBI (LODR) Regulations 2015",
      "datetime": "13-Nov-2026",
      "details": "Submission of standalone & Consolidated Unaudited Financial Results along with limited review report statement of assets and liabilities and cash flow statements for the Quarter and Half year ended on 30th September 2026 pursuant to regulation 33(3) of the SEBI (LODR) Regulations 2015",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Submission Of Standalone & Consolidated Unaudited Financial Results For The Quarter And Half Year Ended On 30Th September 2026 Pursuant To Regulation 33(3) Of The SEBI (LODR) Regulations 2015.",
      "datetime": "13-Nov-2026",
      "details": "Pursuant to Regulation 33(3) of SEBI (LODR) Regulations 2015 we are pleased to submit herewith the following:",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Syncom Formulations (India) Ltd has declared <strong>10%</strong> dividend, ex-date: 23 Sep 26",
          "dt": "2026-09-23",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Syncom Formulations (India) Ltd has announced <strong>1:10</strong> stock split, ex-date: 19 Aug 13",
          "dt": "2013-08-19",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Syncom Formulations (India) Ltd has announced <strong>5:2</strong> bonus issue, ex-date: 19 Aug 13",
          "dt": "2013-08-19",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Syncom Formulations (India) Ltd has announced <strong>1:2</strong> rights issue, ex-date: 13 May 09",
          "dt": "2009-05-13",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

14-Nov-2026 | Source : BSE

Submission of Press Clipping regarding publication of extract of Unaudited Standalone and Consolidated Financial Results for the Quarter/Half Year ended on 30th September 2026

Submission Of Standalone & Consolidated Unaudited Financial Results For The Quarter And Half Year Ended On 30Th September 2026 Pursuant To Regulation 33(3) Of The SEBI (LODR) Regulations 2015

13-Nov-2026 | Source : BSE

Submission of standalone & Consolidated Unaudited Financial Results along with limited review report statement of assets and liabilities and cash flow statements for the Quarter and Half year ended on 30th September 2026 pursuant to regulation 33(3) of the SEBI (LODR) Regulations 2015

Board Meeting Outcome for Submission Of Standalone & Consolidated Unaudited Financial Results For The Quarter And Half Year Ended On 30Th September 2026 Pursuant To Regulation 33(3) Of The SEBI (LODR) Regulations 2015.

13-Nov-2026 | Source : BSE

Pursuant to Regulation 33(3) of SEBI (LODR) Regulations 2015 we are pleased to submit herewith the following:

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Syncom Formulations (India) Ltd has declared 10% dividend, ex-date: 23 Sep 26

stock-summary
SPLITS

Syncom Formulations (India) Ltd has announced 1:10 stock split, ex-date: 19 Aug 13

stock-summary
BONUS

Syncom Formulations (India) Ltd has announced 5:2 bonus issue, ex-date: 19 Aug 13

stock-summary
RIGHTS

Syncom Formulations (India) Ltd has announced 1:2 rights issue, ex-date: 13 May 09